Redenlab awarded $2.5M to scale AI-driven speech biomarkers for dementia detection →
A newly formed research network focused on Batten disease, a rare and inherited brain disorder that primarily affects children, has received funding from the U.S. National Institutes of Health (NIH) to accelerate clinical research and prepare for future treatment trials.
Receiving the CUREator+ Dementia & Cognitive Decline funding marks a meaningful milestone in our journey to transform how we measure and monitor cognitive health.
In this study, Thayabaran Kathiresan, Redenlab’s Director of Audio Engineering, co-authors "Cortical-striatal brain network distinguishes deepfake from real speaker identity”....